VentureWell
Through the Blueprint MedTech Incubator Hubs Program, VentureWell provides commercialization support to Stanford University scientists who are developing an artificial retina.
Following a recent BME-IDEA panel, VentureWell President and CEO Phil Weilerstein reflects on how to prepare the next generation of innovators for a healthcare landscape increasingly shaped by AI.
Of the forces reshaping innovation, these stand out as signals of deeper, structural shifts in how science- and technology-based innovation is evolving.
Transformative health technology is heading to maternity care deserts nationwide.
VentureWell’s Chelsea Schiller reflects on a period of advancing commercialization readiness, leveraging network expertise, and convening network members.
The field of women’s health has evolved rapidly, coalescing into a powerful new movement. VentureWell’s unique capabilities help ensure that every dollar directed toward women’s health can make an outsized impact.
VentureWell alumni offer advice to healthtech innovators.
Explore key findings from the Investor Catalyst Hub’s network survey.
The ARPA-H Investor Catalyst Hub connected Belle.ai to spokes within its network that could help it validate its customer segments.
ReBlood Rx, founded by Carlos Munoz and Christopher Caballero, has developed a revolutionary hemoglobin-based oxygen delivery system—essentially a blood alternative.
As the Commercialization Center, VentureWell provided infrastructure support for a life-saving hepatitis C test-to-treat breakthrough.
LymeAlert created a kit to help people identify whether a tick carries Lyme-causing bacteria—right at home.
Jason Kang, co-founder of Aspire alumnus Kinnos, shares advice for other early-stage founders.
With support from VentureWell, the RADx® ITAP healthcare innovation and commercialization program has produced a faster and more convenient mpox test.
Spoke members gathered in Atlanta, Georgia, to share ideas and foster collaboration within the Southeast health innovation ecosystem.
Co-founders and twin brothers Daniel Lundberg and David Lundberg explain why they built sustainability into their medtech company, T33 Dental, and how other startups can do the same.
Just over a year ago, the Advanced Research Projects Agency for Health (ARPA-H) launched the Investor Catalyst (IC) Hub as part of ARPANET-H—a nationwide health innovation network.
Kendra Batchelder, co-founder of WAVED Medical, explains how the Qualcomm Innovator Stipend Program helped pay for legal fees associated with securing rights to intellectual property.
The Advanced Research Projects Agency for Health and the Center for Devices and Radiological Health of the FDA announced the exploration of a new initiative.
Max Derbyshire, COO of Acorn Genetics, shares how the E-Team Program and the Aspire investor-engagement program advanced his innovation.
First Name
Last Name
Your email
Yes I would like receive weekly newsletters from VentureWell
I'd best describe myself as a: StudentStartupFaculty MemberResearcherOther
By continuing to use the site, you agree to the use of cookies. Read MoreAccept